Back to News
Market Impact: 0.25

Why is Nvidia stock falling despite China chip export resumption

NVDA
TGT
Artificial IntelligenceSanctions & Export ControlsTechnology & InnovationCompany FundamentalsAnalyst Insights
Why is Nvidia stock falling despite China chip export resumption

Nvidia shares fell ~1.2% as investors weighed renewed expectations of H200 AI chip exports to China alongside tighter U.S. export-control scrutiny. The selloff occurred despite positive catalysts, including KeyBanc raising its price target, Jensen Huang’s outlook on next-gen AI hardware production, and a new partnership milestone with Nokia.

Analysis

The important read-through is that NVDA is trading less like a pure demand story and more like a policy-optionality name. Near-term revenue from compliant China shipments matters, but the bigger variable is whether Washington keeps narrowing the addressable market for each GPU generation; that is what can cap the multiple even if unit demand stays strong. The real valuation driver over the next 6-18 months remains Blackwell ramp, networking attach, and the company’s ability to keep gross margin elevated while mix shifts to newer systems.

Second-order winners are AI infrastructure names with less direct export-control sensitivity: ANET and, to a lesser extent, TSM and the advanced-packaging stack if global AI capex keeps compounding regardless of China restrictions. The losers are the China-sensitive edge of the ecosystem—local accelerator vendors and any ODMs trying to arbitrage U.S. chips into Chinese deployments—because every new rule revision raises substitution toward domestic silicon and lowers visibility on procurement cycles. If licensing friction increases, NVDA may still protect share, but the market will likely compress the policy premium rather than the growth premium.

The contrarian view is that the stock may already be discounting a worse China outcome than the base case: the earnings hit from restricted SKUs is probably smaller than the multiple risk from headline uncertainty. A clean policy clarification could rerate the shares quickly, but a broadened rule set or delayed approvals would be the faster downside catalyst over the next 2-6 weeks. Falsifier: if management guides China-related revenue/GM lower or if Washington expands the control list, the current stabilization thesis is wrong; if not, the selloff looks like a volatility event rather than a fundamentals break.